特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の次世代シーケンシングインフォマティクス市場:サービスタイプ別、用途別、エンドユーザー別、地域別 - 成長、動向、予測

Next-Generation Sequencing Informatics Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 613102
出版日 ページ情報 英文 112 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.61円で換算しております。
世界の次世代シーケンシングインフォマティクス市場:サービスタイプ別、用途別、エンドユーザー別、地域別 - 成長、動向、予測 Next-Generation Sequencing Informatics Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年06月01日 ページ情報: 英文 112 Pages
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
概要

世界の次世代シーケンシングインフォマティクス市場は2018~2023年にかけCAGR22.0%となる見通しです。次世代シーケンシングインフォマティクス製品・サービスの需要の高まりから、北米が同市場を独占しています。

当レポートでは、世界の次世代シーケンシングインフォマティクス市場について調査し、市場の概要と成長動向、競合動向、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響因子

第5章 市場概要

  • 現在の市場シナリオ
  • ポーターズファイブフォース分析

第6章 促進因子、阻害因子、機会、課題分析

  • 促進因子
  • 阻害因子
  • 市場機会
  • 課題

第6章 市場セグメンテーション

  • サービスタイプ別
    • インフォマティクスツール
    • データ解析ツール
    • ストレージ・コンピューティングツール
    • 解釈・レポーティングツール
    • 試験所情報管理システム(LIMS)
  • 用途別
    • 創薬
    • 遺伝子スクリーニング
    • 疾患診断
    • 精密医療
    • その他
  • エンドユーザー別
    • 病院
    • 学術研究機関
    • 製薬会社・バイオテクノロジー企業
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第8章 競合環境

  • 合併・買収
  • 協定、連携、提携
  • 新製品上市

第9章 主要企業

  • Amazon Web Services LLC
  • Dnanexus Inc.
  • F. Hoffmann-La Roche Ltd
  • Genomatrix AG
  • Illumina Inc.
  • Omicia Inc.
  • Partek Incorporated
  • Qiagen NV
  • Sapio Sciences
  • Thermo Fischer Scientific Inc.
  • その他

第10章 市場の将来

目次
Product Code: 57019

The major factors driving the growth of next-generation sequencing informatics market studied are the increasing clinical applications of next-generation sequencing (NGS), technological advancements in NGS informatics tools, growing preference toward personalized medicines and early disease diagnosis, and increasing demand for NGS services and investments by key players. Applications include whole-genome and transcriptome sequencing, metagenomic characterization of microbial types in environmental and clinical specimens, explanation of DNA binding sites for chromatin and regulatory proteins, and targeted re-sequencing of specific sites in the human genome, identified by linkage analyses. The unavailability of skilled professionals for the analysis and data interpretations of NGS data, along with the lack of knowledge of new informatics tools among medical professionals, is likely to limit the growth of the market studied. Additionally, the high cost involved in the maintenance and security of informatics tools is likely to contribute to the limitation.

Key Market Trends

Genetic Screening Segment, by Application, is Expected to Experience the Fastest Growth Rate in the Market

There are several companies in the market that provide NGS services for a range of genetic disorders and screening of DNA, RNA, and specialized samples like T-cells and B-cells, such as MedGenome. In the files of clinical medical genetics, the molecular diagnosis to detect inherited genetic defects requires massive parallel sequencing. For the analysis of exome sequencing, there are multiple publicly available single nuclear polymorphism (SNP) databases, population allele frequency, and computational algorithms for function prediction, for the detection of a bulk of variants in genetic screening.

There is a high scope of technological improvement in the application of NGS, in genetic testing. Recently, NGS-based genetic screening and interpretation have been useful for improving hearing-loss testing. Recently, as per a paper published in 2018, in the Journal of Fertility and Sterility, the pre-implantation genetic screening using NGS, significantly improved the pregnancy outcomes as compared to an array of comparative genomic hybridization. Therefore, NGS has a large number of varied application through genetic screening in multiple disorders, but their affordability and availability in high-income and low-income countries may differ a lot. Thus, steady growth is expected in the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market throughout the forecast period. The presence of high per capita healthcare expenditure, coupled with high patient awareness levels and high prevalence of target diseases, is contributing to the growth of the market studied in the region. In the North American region, the United States holds the largest market share.

Competitive Landscape

The next-generation sequencing informatics market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising patient awareness levels and high prevalence of target diseases, few other smaller players are expected to enter the market. Some of the major players of the market are Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Intrexon Bioinformatics Germany GmbH, and Illumina Inc., among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Clinical Applications of NGS
    • 4.2.2 Technological Advancements in NGS Informatics Tools
    • 4.2.3 Growing Preference toward Personalized Medicines and Early Disease Diagnosis
    • 4.2.4 Increasing Demand for NGS Services and Rising Investment by Key Players
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Technicians for NGS Informatics Services
    • 4.3.2 Challenges Associated with Data Storage and Integration
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Products and Services
    • 5.1.1 NGS Informatics Services
    • 5.1.2 Data Analysis and Management Tool
      • 5.1.2.1 Storage and Computing Tool
      • 5.1.2.2 Laboratory Information Management System (LIMS)
      • 5.1.2.3 Data Interpretation and Reporting Tools
    • 5.1.3 Primary and Secondary Data Analysis Tools
  • 5.2 By Application
    • 5.2.1 Drug Discovery
    • 5.2.2 Genetic Screening
    • 5.2.3 Precision Medicine
    • 5.2.4 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Academics and Research Institutes
    • 5.3.3 Pharmaceuticals Companies
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies Inc.
    • 6.1.2 Dnanexus Inc.
    • 6.1.3 F. Hoffmann-La Roche Ltd
    • 6.1.4 Intrexon Bioinformatics Germany GmbH (Genomatrix AG)
    • 6.1.5 llumina Inc.
    • 6.1.6 Fabric Genomics Inc. (Omicia Inc.)
    • 6.1.7 Partek Incorporated
    • 6.1.8 Qiagen NV
    • 6.1.9 Sapio Sciences
    • 6.1.10 Thermo Fischer Scientific Inc.
    • 6.1.11 DNASTAR Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS